Prostate cancer metastatic Trials in Portland, United States
Conditions / Prostate cancer metastatic / Portland, United States
Prostate cancer metastatic is a medical condition with active clinical research programs worldwide.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04452136 | Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer | APPROVED_FOR_MARKETING | — |
| NCT03888612 | Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer | COMPLETED | PHASE1/PHASE2 |
| NCT04028388 | ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer | COMPLETED | PHASE2 |
| NCT04848337 | Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04116775 | Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. | UNKNOWN | PHASE2 |
| NCT05177042 | Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer | COMPLETED | — |
| NCT01487863 | Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer | COMPLETED | PHASE2 |
| NCT06136624 | Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) | RECRUITING | PHASE3 |
| NCT03761017 | MGD019 DART® Protein in Unresectable/Metastatic Cancer | COMPLETED | PHASE1 |
| NCT05553639 | HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer | TERMINATED | PHASE1/PHASE2 |